Jundishapur Journal of Microbiology

Published by: Kowsar

Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran

Ahya Abdi-Ali 1 , * , Saghar Hendiani 1 , Parisa Mohammadi 1 and Sara Gharavi 1
Authors Information
1 Department of Biology, Faculty of Science, Alzahra University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: January 01, 2014, 7 (1); e8606
  • Published Online: January 1, 2014
  • Article Type: Research Article
  • Received: October 28, 2012
  • Revised: January 12, 2013
  • Accepted: January 23, 2013
  • DOI: 10.5812/jjm.8606

To Cite: Abdi-Ali A, Hendiani S, Mohammadi P, Gharavi S. Assessment of Biofilm Formation and Resistance to Imipenem and Ciprofloxacin among Clinical Isolates of Acinetobacter baumannii in Tehran, Jundishapur J Microbiol. 2014 ; 7(1):e8606. doi: 10.5812/jjm.8606.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284(5418): 1318-22[PubMed]
  • 2. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15(2): 167-93[PubMed]
  • 3. Lindsay D, von Holy A. Bacterial biofilms within the clinical setting: what healthcare professionals should know. J Hosp Infect. 2006; 64(4): 313-25[DOI][PubMed]
  • 4. Stoodley P, Sauer K, Davies DG, Costerton JW. Biofilms as complex differentiated communities. Annu Rev Microbiol. 2002; 56: 187-209[DOI][PubMed]
  • 5. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersboll BK, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology. 2000; 146 ( Pt 10): 2395-407[PubMed]
  • 6. Van Looveren M, Goossens H. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect. 2004; 10(8): 684-704[DOI][PubMed]
  • 7. Kazemi Pour Nadia, Dusane Devendra H, Dhakephalkar Prashant K, Zamin Farokh Rokhbakhsh, Zinjarde Smita S, Chopade Balu A. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol. 2011; 62(3): 328-338
  • 8. Chang Shan-Chwen, Chen Yee-Chun, Luh Kwen-Tay, Hsieh Wei-Chuan. In vitro activites of antimicrobial agents, alone and in combination, against Acinetobacter baumannii isolated from blood. Diagnos Microbiol Infect Dis. 1995; 23(3): 105-110[DOI]
  • 9. Chu YW, Afzal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford N, et al. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 2001; 45(3): 710-4[DOI][PubMed]
  • 10. Stepanović Srdjan, Vuković Dragana, Dakić Ivana, Savić Branislava, Švabić-Vlahović Milena. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiological Methods. 2000; 40(2): 175-179[DOI]
  • 11. Ali Oau. Prevention of Proteus mirabilis biofilm by surfactant solution. Egypt Acad J Biolog Sci. 2012; 4: 1-8
  • 12. Wikler Matthew A. Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement. 2006;
  • 13. Gehrlein M, Leying H, Cullmann W, Wendt S, Opferkuch W. Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins. Chemotherapy. 1991; 37(6): 405-12[PubMed]
  • 14. Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2008; 26(4): 333-7[PubMed]
  • 15. Deighton MA, Balkau B. Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections. J Clin Microbiol. 1990; 28(11): 2442-7[PubMed]
  • 16. Beck-Sague CM, Jarvis WR, Brook JH, Culver DH, Potts A, Gay E, et al. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol. 1990; 132(4): 723-33[PubMed]
  • 17. Vidal R, Dominguez M, Urrutia H, Bello H, Garcia A, Gonzalez G, et al. Effect of imipenem and sulbactam on sessile cells of Acinetobacter baumannii growing in biofilm. Microbios. 1997; 91(367): 79-87[PubMed]
  • 18. Seifert H, Baginski R, Schulze A, Pulverer G. Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother. 1993; 37(4): 750-3[PubMed]
  • 19. Vidal R, Dominguez M, Urrutia H, Bello H, Gonzalez G, Garcia A, et al. Biofilm formation by Acinetobacter baumannii. Microbios. 1996; 86(346): 49-58[PubMed]
  • 20. Bauernfeind A, Kljucar S, Jungwrith R. Overview of antibiotic resistance problems in Acinetobacter spp. In: Clinical importance and antibiotic resistance of Acinetobacter spp. J Med Microbiol. 1997; (46): 726-8
  • 21. Tolker-Nielsen T, Brinch UC, Ragas PC, Andersen JB, Jacobsen CS, Molin S. Development and dynamics of Pseudomonas sp. biofilms. J Bacteriol. 2000; 182(22): 6482-9[PubMed]
  • 22. Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, Ayala JA, Perea EJ, Pascual A. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother. 2003; 51(3): 565-74[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments